A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 330 participants.
Also called NCT07373613
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 330 participants
- Registry
-
NCT07373613
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07373613. Randomized; double masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2027-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- BR1400-1
- Intervention (Drug)
- BR1400-2
- Intervention (Drug)
- BR1400-3
- Intervention (Drug)
- BR1400-4
- Intervention (Drug)
- BR1400-5
- Intervention (Drug)
- BR1400-A
- Intervention (Drug)
- BR1400-B
- Intervention (Drug)
- BR1400-C
- Lead sponsor
- Boryung Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct07373613- Content hash
32a91c01d9d2f74d7e93516c65ab442c713ce452b89bd5c1a2c903736dd7a342